Status:

COMPLETED

Spectrum Analysis in Ex-vivo Human Lungs

Lead Sponsor:

University Health Network, Toronto

Conditions:

Lung Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will analyze spectral features of the radiofrequency of lung tumors in ex-vivo human lungs. The resected specimens will be evaluated using the spectrum analysis to determine the localizatio...

Eligibility Criteria

Inclusion

  • Any patients scheduled for lobectomy of anatomical segmental resection for malignant lung tumors.
  • 18 years of age or older

Exclusion

  • Any patients with inability to give informed consent.

Key Trial Info

Start Date :

July 12 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2018

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03356743

Start Date

July 12 2017

End Date

May 1 2018

Last Update

May 4 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Toronto General Hospital

Toronto, Ontario, Canada, M5G 2C4

Spectrum Analysis in Ex-vivo Human Lungs | DecenTrialz